Follow
Shuhei Kawamura
Shuhei Kawamura
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
A general alkyl-alkyl cross-coupling enabled by redox-active esters and alkylzinc reagents
T Qin, J Cornella, C Li, LR Malins, JT Edwards, S Kawamura, BD Maxwell, ...
Science 352 (6287), 801-805, 2016
6432016
Practical Ni-catalyzed aryl–alkyl cross-coupling of secondary redox-active esters
J Cornella, JT Edwards, T Qin, S Kawamura, J Wang, CM Pan, ...
Journal of the American Chemical Society 138 (7), 2174-2177, 2016
4372016
Nineteen-step total synthesis of (+)-phorbol
S Kawamura, H Chu, J Felding, PS Baran
Nature 532 (7597), 90-93, 2016
2112016
Simple Sulfinate Synthesis Enables C H Trifluoromethylcyclopropanation
R Gianatassio, S Kawamura, CL Eprile, K Foo, J Ge, AC Burns, ...
Angewandte Chemie 126 (37), 10009-10013, 2014
1562014
Potent Proteasome Inhibitors Derived from the Unnatural cis-Cyclopropane Isomer of Belactosin A: Synthesis, Biological Activity, and Mode of Action
S Kawamura, Y Unno, A List, A Mizuno, M Tanaka, T Sasaki, M Arisawa, ...
Journal of medicinal chemistry 56 (9), 3689-3700, 2013
552013
Cyclopropane-based conformational restriction of GABA by a stereochemical diversity-oriented strategy: Identification of an efficient lead for potent inhibitors of GABA transports
K Nakada, M Yoshikawa, S Ide, A Suemasa, S Kawamura, T Kobayashi, ...
Bioorganic & medicinal chemistry 21 (17), 4938-4950, 2013
442013
Synthesis and pharmacological evaluation of nucleoside prodrugs designed to target siderophore biosynthesis in Mycobacterium tuberculosis
S Dawadi, S Kawamura, A Rubenstein, R Remmel, CC Aldrich
Bioorganic & medicinal chemistry 24 (6), 1314-1321, 2016
362016
Allosteric modulation of protein arginine methyltransferase 5 (PRMT5)
RL Palte, SE Schneider, MD Altman, RP Hayes, S Kawamura, BM Lacey, ...
ACS Medicinal Chemistry Letters 11 (9), 1688-1693, 2020
342020
Discovery of diaminopyrimidine carboxamide HPK1 inhibitors as preclinical immunotherapy tool compounds
BA Vara, SM Levi, A Achab, DA Candito, X Fradera, CA Lesburg, ...
ACS Medicinal Chemistry Letters 12 (4), 653-661, 2021
272021
Structurally novel highly potent proteasome inhibitors created by the structure-based hybridization of nonpeptidic belactosin derivatives and peptide boronates
S Kawamura, Y Unno, A Asai, M Arisawa, S Shuto
Journal of medicinal chemistry 57 (6), 2726-2735, 2014
272014
Investigation of the noncovalent binding mode of covalent proteasome inhibitors around the transition state by combined use of cyclopropylic strain-based conformational …
S Kawamura, Y Unno, M Tanaka, T Sasaki, A Yamano, T Hirokawa, ...
Journal of Medicinal Chemistry 56 (14), 5829-5842, 2013
272013
Identification of potent reverse indazole inhibitors for HPK1
EC Yu, JL Methot, X Fradera, CA Lesburg, BM Lacey, P Siliphaivanh, ...
ACS Medicinal Chemistry Letters 12 (3), 459-466, 2021
232021
Rational hopping of a peptidic scaffold into non-peptidic scaffolds: structurally novel potent proteasome inhibitors derived from a natural product, belactosin A
S Kawamura, Y Unno, T Hirokawa, A Asai, M Arisawa, S Shuto
Chemical communications 50 (19), 2445-2447, 2014
232014
Isolation and structure characterization of cytotoxic phorbol esters from the seeds of Croton tiglium
Q Du, Y Zhao, H Liu, C Tang, M Zhang, C Ke, Y Ye
Planta medica 83 (17), 1361-1367, 2017
222017
Design and synthesis of the stabilized analogs of belactosin A with the unnatural cis-cyclopropane structure
S Kawamura, Y Unno, A Asai, M Arisawa, S Shuto
Organic & biomolecular chemistry 11 (38), 6615-6622, 2013
212013
The discovery of two novel classes of 5, 5-bicyclic nucleoside-derived prmt5 inhibitors for the treatment of cancer
RV Quiroz, MH Reutershan, SE Schneider, D Sloman, BM Lacey, ...
Journal of Medicinal Chemistry 64 (7), 3911-3939, 2021
182021
Asymmetric Reductive Dicarbofunctionalization of Alkenes via Nickel Catalysis
D Anthony, T Diao
Synlett 31 (15), 1443-1447, 2020
122020
Development of a new class of proteasome inhibitors with an epoxyketone warhead: rational hybridization of non-peptidic belactosin derivatives and peptide epoxyketones
S Kawamura, Y Unno, A Asai, M Arisawa, S Shuto
Bioorganic & Medicinal Chemistry 22 (12), 3091-3095, 2014
92014
Design and synthesis of unprecedented 9-and 10-membered cyclonucleosides with PRMT5 inhibitory activity
S Kawamura, RL Palte, HY Kim, J Saurí, C Sondey, MS Mansueto, ...
Bioorganic & Medicinal Chemistry 66, 116820, 2022
52022
Ligand–Phospholipid Conjugation: A Versatile Strategy for Developing Long-Acting Ligands That Bind to Membrane Proteins by Restricting the Subcellular Localization of the Ligand
S Kawamura, Y Ito, T Hirokawa, E Hikiyama, S Yamada, S Shuto
Journal of Medicinal Chemistry 61 (9), 4020-4029, 2018
32018
The system can't perform the operation now. Try again later.
Articles 1–20